Gilead Sciences Inc. is looking to strengthen its development of new drugs in Japan beyond those for the hepatitis C virus (HCV). This follows the company having burst onto the...
pharmaceutical
Kyokuto Looks to Produce Animal Serum Culture Media for Regenerative Medicine
Kyokuto Pharmaceutical Industrial Co. Ltd. is looking to turn products for the regenerative medicine sector into a new pillar of business. The company, which manufactures and sells the likes of...
METI Promotes Shift to Continuous-Flow Production for Functional Chemicals
The Ministry of Economy, Trade and Industry (METI) is promoting a shift from batch production to continuous-flow production for functional chemicals such as pharmaceutical and agricultural intermediates. METI’s efforts here...
Meiji Seika Pharma Looks to Double Production Capacity for Injectable Antibacterials
Meiji Seika Pharma Co. Ltd. is gearing up to strengthen its production capacity for injection-administered antibacterial drugs. Holding the top share of Japan’s antibacterial market, and continuing to operate at...
Sumitomo Dainippon Pharma Targets GMP-Based Mass Production of Cellular Medicine
Sumitomo Dainippon Pharma Co. Ltd. (TYO:4506) is working toward the mass production of cellular pharmaceuticals for regenerative medicines derived from allogenic induced pluripotent stem (iPS) cells. Medicine produced through this...
Otsuka Pharmaceutical Plans Launch of Antipsychotic Pills With Embedded Mini-Sensors
Otsuka Pharmaceutical Co. Ltd. is targeting a U.S. rollout beginning as soon as this year for Abilify MyCite – a world-first “digital medicine” that incorporates medical devices into pills. The...
Chugai Pharmaceutical Targets Lower Investment and Maintenance Costs With Next-Gen Plant
Chugai Pharmaceutical Co. Ltd. (TYO:4519) has begun preparations for a new plant emphasizing cost and speed. The company is looking to reduce the initial investment and maintenance costs for this...
Ube Industries Plans Full-Scale Entry Into Drug Substance Market for Generics
Ube Industries Ltd. (TYO:4208) is looking to enter into the market of pharmaceutical ingredients for use in generic drugs by the end of this year. The company already engages in...
Sumitomo Rubber Limits Biopharmaceutical Deterioration With New Prefilled Syringe Stopper
Sumitomo Rubber Industries Ltd. (TYO:5110) has developed a rubber stopper that inhibits deterioration in biopharmaceuticals. Liquid biopharmaceuticals are delivered to end users in prefilled syringes that already contain the drug....
Fujifilm to Test Mass Production of Microneedle Arrays
Fujifilm Holdings Corp. (TYO:4901) is looking to accelerate the practical application of microneedle arrays – a drug delivery technology whereby a sheet adheres to the patient’s skin and administers drugs...
Nitto Denko Targets Life Science as Third Business Pillar
Nitto Denko Corp. (TYO:6988) is looking to rear its life science operations into a third key pillar of business. Fiscal 2017 sales for Nitto Denko totaled 856.3 billion yen ($7.82...
Interview: Takeda Pharmaceutical CEO Talks Shire Deal, Shifting Business Structure – Part 2
Takeda Pharmaceutical Co. Ltd. (TYO:4502) has recently made waves in the pharmaceutical industry with its move to acquire Irish-based drug manufacturer Shire PLC. President and CEO Christophe Weber recently took...
Interview: Takeda Pharmaceutical CEO Talks Shire Deal, Shifting Business Structure – Part 1
Takeda Pharmaceutical Co. Ltd. (TYO:4502) is bringing Irish-based drug manufacturer Shire PLC under its umbrella. Entailing an acquisition price of around 46 billion pounds ($62.4 billion), this is the largest...
Taiyo Holdings Looks to Produce Drugs In-House
Taiyo Holdings Co. Ltd. (TYO:4626) has acquired long-listed drug business operations from Chugai Pharmaceutical Co. Ltd. (TYO:4519), and plans to acquire its own factory within the fiscal year to produce...
Interview: Novartis Pharma President Kazunari Tsunaba Talks Market Adjustments, New Treatments and Technologies
Novartis Pharma KK appears to have turned the corner in terms of business performance. Sitting down for an interview with The Chemical Daily, president Kazunari Tsunaba said that sales for...
Memory T Cells Found to Alter Immunological Response Based on Intensity of Antigenic Stimulation
An international research group formed by the Institute of Physical and Chemical Research (Riken), Osaka University and Yale University has discovered that the strength at which memory T cells are...
NOF Develops Monodisperse PEG for Antibody Drug Delivery
NOF Corp. (TYO:4403) has developed a monodisperse polyethylene glycol (PEG) as a drug delivery system (DDS) material usable in antibody drugs. Sales of the PEG began in March. Unlike typical...
Western Chemical Companies in Japan – Part 12: Occidental Chemical
The Chemical Daily recently conducted a round of interviews with the heads of Japanese subsidiaries of Western chemical companies. For this installment, we talked with Toru Ogawa, president of Occidental...
Nihon Medi-Physics Embarks on Development of New Cancer Treatment
Nihon Medi-Physics Co. Ltd., a radiopharmaceutical manufacturing venture equally funded by Sumitomo Chemical Co. Ltd. (TYO:4005) and GE Healthcare, will begin working toward the establishment of theranostics – a completely...
Mitsubishi Chemical Looks to Accelerate M&A Efforts in Performance Products
Mitsubishi Chemical Corp. is moving to accelerate its M&A strategies in the area of performance products. With an investment and loan framework of 1.7 trillion yen ($15.08 billion) established as...
